8TN5

The Crystal Structure of a human monoclonal antibody (aAb), termed TG10, complexed with a GlcNH2

8TN5 の概要

• エントリーDOI: 10.2210/pdb8tn5/pdb
• 分子名称: TG10, Heavy chain, TG10, Light chain, SULFATE ION, ... (6 entities in total)
• 機能のキーワード: monoclonal antibody, tg10, glcnac, immune system
• 由来する生物種: Homo sapiens (human); 詳細
• タンパク質・核酸の鎖数: 2
• 化学式量合計: 48066.43

構造登録者

Li, M.,Wlodawer, A.,Temme, S.,Gildersleeve, J. (登録日: 2023-08-01, 公開日: 2024-12-04, 最終更新日: 2025-06-18)

主引用文献

Temme, J.S.,Tan, Z.,Li, M.,Yang, M.,Wlodawer, A.,Huang, X.,Schneekloth Jr., J.S.,Gildersleeve, J.C.
Insights into biofilm architecture and maturation enable improved clinical strategies for exopolysaccharide-targeting therapeutics.
Cell Chem Biol, 31:2096-2111.e7, 2024

PubMed Abstract: Polysaccharide intercellular adhesin (PIA), an exopolysaccharide composed of poly-N-acetyl glucosamine (PNAG), is an essential component in many pathogenic biofilms. Partial deacetylation of PNAG is required for biofilm formation, but limited structural knowledge hinders therapeutic development. Employing a new monoclonal antibody (TG10) that selectively binds highly deacetylated PNAG and an antibody (F598) in clinical trials that binds highly acetylated PNAG, we demonstrate that PIA within the biofilm contains distinct regions of highly acetylated and deacetylated exopolysaccharide, contrary to the previous model invoking stochastic deacetylation throughout the biofilm. This discovery led us to hypothesize that targeting both forms of PNAG would enhance efficacy. Remarkably, TG10 and F598 synergistically increased in vitro and in vivo activity, providing 90% survival in a lethal Staphylococcus aureus challenge murine model. Our advanced model deepens the conceptual understanding of PIA architecture and maturation and reveals improved design strategies for PIA-targeting therapeutics, vaccines, and diagnostic agents.

PubMed: 39637855
DOI: 10.1016/j.chembiol.2024.11.005

実験手法

X-RAY DIFFRACTION (1.76 Å)